Powered by Clearbit
CONMED Corp (NYS: CNMD)+ to Company Analysis List
Address: 11311 Concept Blvd.,Largo, FL 33773 United States  |  Phone: 727 392-6464  |  Fax: 315 797-0321  |  Company Website: www.conmed.com

Incorporated: February 1970 , NY, United States

IRS Number: 160977505

Auditor: PricewaterhouseCoopers LLP

Legal Counsel: Sullivan & Cromwell,Daniel S. Jonas, Esq.

Transfer Agent: Registrar and Transfer Company, Cranford, NJ

Country:  United States

Industry: Medical Supplies (ICB 20102015)

Industry: Electromedical equipment (SIC 3845)

Industry: Electromedical and Electrotherapeutic Apparatus Manufacturing (NAICS 334510)

Number of Employees: 4,100 (Approximate Full-Time as of 12/31/2022)

Number of Shareholders: 468 (registered), 61,445 (approx. street name) (as of 02/06/2023)

Market Cap: 2,052,903,110

Revenue: 1,275,993,000

Net Income: 98,593,000

Dividend: 0.8    Dividend Yield: 1.2014

EPS Basic: 3.21    EPS Diluted: 3.14

PE Ratio: 21.207

Synopsis Highlights History Business Property Subsidiaries Long term debt Capital stock Earnings estimates Business segments
Download  Printer Friendly My Mergent Tools
Company Analysis List (0/500)
No company added to the Company Analysis List
Executive List (0/500)
No executive added to the Executive List
Mergent Private Company List (0/500)
No company added to the Mergent Private Company List
Company Alerts (0)
No alerts added to Alerts
Executive Alerts (0)
No alerts added to Executive Alerts

Business Summary

CONMED is a medical technology company that provides devices and equipment for surgical procedures. Co.'s product lines consist of orthopedic surgery and general surgery. Co.'s orthopedic surgery provides products that support sports medicine, the repair of soft tissue in the knee, hip, shoulder and in the upper and lower extremities. Co. also provides its customers with a line of battery-powered, autoclavable, large and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal and cardiothoracic surgeries. Co.'s general surgery product line provides a range of products in the areas of advanced surgical and advanced endoscopic technologies.

Pricing Summary


Time Period


 Yesterday5 Days30 Days
Close66.5971.9274.31
Volume461,560.00475,866.00550,322.00
 
52 Week High/Low : N/A - N/A
% Price Change (100 Days) : -1.35
200-Day Moving Avg. : 71.96


Company News

Corporate Events
















Key Executives

Age 
Chairman61
 
AgeSalary
President,Chief Executive Officer51842,489
 
 Salary
Executive Vice President,Chief Financial Officer439,187
 
AgeSalary
Executive Vice President,Chief Financial Officer50398,820
 
AgeSalary
Executive Vice President,General Counsel51326,762
 

Key Financials

(In USD as of 06/30/2024)

Income Statement
Revenue1,276m
Net Income99m
EPS from Continuing Operations3.14
EPS - Net Income - Diluted3.14
Revenue per Share41.41
Balance Sheet
Total Assets2,286m
Total Liabilities1,404m
Shareholders' Equity882m
Total Assets per Share74.15
Net Assets per Share28.61
Cash Flows
Cash from Operations175m
Cash from Investing-16m
Cash from Financing-157m
Capital Expenditures16m
Cash Flow per Share5.62